Spero Therapeutics Inc
F:2HA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Spero Therapeutics Inc
F:2HA
|
US |
|
N
|
Nordstrom Inc
F:NRD
|
US |
|
A
|
Abeona Therapeutics Inc
F:PCJP
|
US |
|
Publicis Groupe SA
F:PU41
|
FR |
|
Toyota Motor Corp
F:TOM
|
JP |
|
A
|
Adevinta ASA
OTC:ADEVF
|
NO |
|
A
|
AXA SA
XMUN:AXA
|
FR |
|
G
|
Grandvision NV
F:8GV
|
NL |
|
F
|
Factset Research Systems Inc
XMUN:FA1
|
US |
|
Novartis AG
F:NOT
|
CH |
|
E
|
Exxaro Resources Ltd
XMUN:LCQ
|
ZA |
|
M
|
Melco Resorts & Entertainment Ltd
SWB:MAS
|
HK |
|
Investec Ltd
OTC:ITCFY
|
ZA |
Dividends
Dividend Yield
Spero Therapeutics Inc
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Spero Therapeutics Inc
2HA have decreased by 0%.
Payout Ratio
Spero Therapeutics Inc
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for 2HA is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
2HA Price
Spero Therapeutics Inc
| Average Annual Return |
N/A
|
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -28% |
| Market Capitalization | 127.5m EUR |
| Shares Outstanding | 1 665 507 |
| Percentage of Shares Shorted |
N/A
|
